Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Net Cash Flow (2018 - 2025)

Historic Net Cash Flow for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to -$10.4 million.

  • Health Catalyst's Net Cash Flow fell 10819.48% to -$10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$287.9 million, marking a year-over-year decrease of 22343.78%. This contributed to the annual value of $143.4 million for FY2024, which is 152590.24% up from last year.
  • As of Q3 2025, Health Catalyst's Net Cash Flow stood at -$10.4 million, which was down 10819.48% from -$291.3 million recorded in Q2 2025.
  • In the past 5 years, Health Catalyst's Net Cash Flow ranged from a high of $126.3 million in Q3 2024 and a low of -$291.3 million during Q2 2025
  • Its 5-year average for Net Cash Flow is -$2.7 million, with a median of $527000.0 in 2024.
  • Per our database at Business Quant, Health Catalyst's Net Cash Flow surged by 90396.31% in 2021 and then plummeted by 5537912.71% in 2025.
  • Health Catalyst's Net Cash Flow (Quarter) stood at -$82.5 million in 2021, then soared by 90.4% to -$7.9 million in 2022, then soared by 242.17% to $11.3 million in 2023, then crashed by 797.24% to -$78.6 million in 2024, then surged by 86.82% to -$10.4 million in 2025.
  • Its Net Cash Flow was -$10.4 million in Q3 2025, compared to -$291.3 million in Q2 2025 and $92.3 million in Q1 2025.